Close Menu

financial guidance

23andMe has sent a letter to the heads of the FDA and NIH asking for help in developing broadly applicable standards and guidelines for providing genetic test results and risk estimates.

Already a pioneer in incorporating pharmacogenetic testing into its PBM programs, Medco's decision to buy DNA Direct signals its intent to be a "one-stop shop" for payors and employers interested in using genetically guided medicine to make healthcare more efficient and lower costs.

Caliper Life Sciences' expected Q4 2009 revenues of $37.6 million exceeds the company's previous guidance of $33 to $35 million.


The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.